Atrium has acquired Nutri-Health Supplements (NHS) for a first consideration of $23.9 million fully paid in cash at the closing of the transaction. Two additional earn-out payments have been structured based on NHS’s 2009 and 2010 EBITDA growth.
This acquisition is reported to be in line with Atrium’s business development strategy since NHS markets, via multi-channel distribution, specialty niche products.
NHS owns proprietary Multi-Probiotic blends which include 16 probiotic strains that are matrix encapsulated to survive stomach acid and deliver a high concentration of active cell cultures per capsule.
Pierre Fitzgibbon, president and CEO of Atrium, said: “Buying Nutri-Health marks our first acquisition into the direct-to-consumer segment with a company aligned with our values and objectives. NHS allows us to acquire complementary expertise in this market segment in which we had a limited business presence until now. This opens the door to promising, synergistic development opportunities within Atrium.”